Skip to content

A study to test different doses of BI 765049 in people with advanced cancer of the colon, rectum, stomach, or pancreas

Status
Suspended
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-519301-36-00
Acronym
1454-0015
Enrollment
40
Registered
2025-06-18
Start date
2025-07-11
Completion date
Unknown
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal carcinoma (CRC)

Interventions

None listed

Sponsors

Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Germany, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026